Enteral trypsin inhibitor for treatment of hemorrhagic shock
A novel enteral trypsin inhibitor is being developed to improve outcomes in hemorrhagic shock by reducing systemic inflammation and organ failure. This targeted therapy avoids complications associated with broad-spectrum...